ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
AstraZeneca
An Associate Director, Access Strategy at AstraZeneca focuses on building relationships with healthcare professionals and developing access strategies for pharmaceutical products. The role involves shaping customer communication strategies, creating value propositions, and leading market access initiatives across various stakeholders.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
AstraZeneca didn’t post a salary, so this is our estimate from similar listings.
Associate Director, CVRM Access Strategy-Wilmington DE
American Association of Physicists in Medicine
Director - CVRM Access Strategy
American Association of Physicists in Medicine
Associate Director - CVRM Access Strategy
American Association of Physicists in Medicine
（Associate） Access Strategy Manager
AbbVie
Executive Director Access Business Partner
City of Duncan, Oklahoma
Senior Director of U.S. Market Access Strategy
Regeneron Pharmaceuticals